The company’s platform functions as an operating system for heart health, integrating clinical, claims, and pharmacy data to identify risks earlier and coordinate patient care. This approach addresses the systemic fragmentation that frequently leads to delayed interventions and excessive hospital utilization. Karoo currently supports a network of over 600 cardiology providers across 11 states, with plans to accelerate engineering and clinical team growth following this investment.

Early performance metrics from deployed programs indicate a reduction of over 40% in emergency department visits and inpatient admissions, alongside a 10% decrease in total cost of care for attributed populations. Lee Shapiro of 7wire Ventures and Jeff Stolte of Allumia Ventures will join the company’s board of directors as part of the financing deal. The funding will specifically target the enhancement of predictive modeling and clinical signal detection capabilities to further scale these outcomes.